Can a rapid test help doctors pick the right antibiotic faster?

NCT ID NCT07491419

Recruiting now Knowledge-focused Sponsor: Istituto Clinico Humanitas Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether a rapid lab test can help doctors choose the right antibiotic sooner for patients with bloodstream infections. About 400 adults with positive blood cultures will be randomly assigned to either the rapid test or standard testing. The goal is to see if the rapid test leads to earlier, more targeted antibiotic use and better patient outcomes.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Rapid Antimicrobial Susceptibility Testing (R-AST) diagnostic test
What this could lead to: If successful, this could show that rapid testing helps doctors prescribe the right antibiotics sooner, potentially improving recovery and reducing antibiotic resistance.
What could go wrong: This is an early-stage diagnostic study, not a treatment trial. The tests may not speed up care or improve outcomes in real-world hospital settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BACTEREMIA SEPSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

bacterial infectious disease with sepsis gram-negative bacterial infections gram-positive bacterial infections Sepsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BACTEREMIA SEPSIS BLOODSTREAM INFECTION GRAM NEGATIVE INFECTIONS GRAM-POSITIVE INFECTIONS

Contacts and locations

Locations

Infectious Disease Unit - IRCCS Humanitas Research Hospital
RECRUITING

Rozzano, Milan, 20089, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.